|
1
|
Tyagi P, Kashyap M, Pore S, Wang Z and
Yoshimura N: MP25-07 prostatic inflammation evokes upergulation of
neurotrophins in sensory ganglia: Possible contribution to
dysfunctional voiding. J Urol. 193:e2872015. View Article : Google Scholar
|
|
2
|
Liao LM, Shi BY and Liang CQ: Ambulatory
urodynamic monitoring of external urethral sphincter behavior in
chronic prostatitis patients. Asian J Androl. 1:215–217.
1999.PubMed/NCBI
|
|
3
|
Ma J, Gharaee-Kermani M, Kunju L,
Hollingsworth JM, Adler J, Arruda EM and Macoska JA: Prostatic
fibrosis is associated with lower urinary tract symptoms. J Urolo.
188:1375–1381. 2012. View Article : Google Scholar
|
|
4
|
Karsdal MA, Genovese F, Madsen EA,
Manon-Jensen T and Schuppan D: Collagen and tissue turnover as a
function of age: Implications for fibrosis. J Hepatol. 64:103–109.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fabre V, Wu H, PondTor S, Coutinho H,
Acosta L, Jiz M, Olveda R, Cheng L, White ES, Jarilla B, et al:
Tissue inhibitor of matrix-metalloprotease1 predicts risk of
hepatic fibrosis in human schistosoma japonicum infection. J Infect
Dis. 203:707–714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Trujillo KA, Heaphy CM, Mai M, Vargas KM,
Jones AC, Vo P, Butler KS, Joste NE, Bisoffi M and Griffith JK:
Markers of fibrosis and epithelial to mesenchymal transition
demonstrate field cancerization in histologically normal tissue
adjacent to breast tumors. Int J Cancer. 129:1310–1321. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silver RB: Role of mast cells in renal
fibrosis. Kidney Int. 84:2142013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cruse G and Bradding P: Mast cells in
airway diseases and interstitial lung disease. Eur J Pharma.
778:125–138. 2016. View Article : Google Scholar
|
|
9
|
Gaca MDA, Arthur MJP and Benyon RC: Mast
cell protease and stem cell factor expression in rat liver
fibrosis. J Hepatol. 28:811998. View Article : Google Scholar
|
|
10
|
Yadav A, Desai RS, Bhuta BA, Singh JS,
Mehta R and Nehete AP: Altered immunohistochemical expression of
mast cell tryptase and chymase in the pathogenesis of oral
submucous fibrosis and malignant transformation of the overlying
epithelium. PLoS One. 9:e987192014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zerr P, Palumbo-Zerr K, Huang J, Tomcik M,
Sumova B, Distler O, Schett G and Distler JH: Sirt1 regulates
canonical TGF-(β) signalling to control fibroblast activation and
tissue fibrosis. Ann Rheum Dis. 75:226–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Summers SA, Gan PY, Dewage L, Ma FT, Ooi
JD, O'Sullivan KM, Nikolic-Paterson DJ, Kitching AR and Holdsworth
SR: Mast cell activation and degranulation promotes renal fibrosis
in experimental unilateral ureteric obstruction. Kidney Int.
82:676–685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeong DH, Lee GP, Jeong WI, Do SH, Yang
HJ, Yuan DW, Park HY, Kim KJ and Jeong KS: Alterations of mast
cells and TGF-beta1 on the silymarin treatment for CCI(4)-induced
hepatic fibrosis. World J Gastroenterol. 11:1141–1148. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Akhmetshina A, Palumbo K, Dees C, Bergmann
C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, et al:
Activation of canonical Wnt signalling is required for
TGF-β-mediated fibrosis. Nat Commun. 3:7352012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Torres P, Poveda A, Jimenez-Barbero J,
Ballesteros A and Plou FJ: Regioselective lipase-catalyzed
synthesis of 3-o-acyl derivatives of resveratrol and study of their
antioxidant properties. J Agric Food Chem. 58:807–813. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sharma S, Anjaneyulu M, Kulkarni SK and
Chopra K: Resveratrol, a polyphenolic phytoalexin, attenuates
diabetic nephropathy in rats. Pharmacology. 76:69–75. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Csiszar A: Anti-inflammatory effects of
resveratrol: Possible role in prevention of age-related
cardiovascular disease. Ann N Y Acad Sci. 1215:117–122. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gharaee-Kermani M, Moore BB and Macoska
JA: Resveratrol-mediated repression and reversion of prostatic
myofibroblast phenoconversion. PLoS One. 11:e01583572016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He Y, Zeng H, Yu Y, Zhang J, Zeng X, Gong
F, Duan X, Liu Q and Yang B: Resveratrol improved the progression
of chronic prostatitis via the downregulation of c-kit/SCF by
activating Sirt1. J Agric Food Chem. 65:5668–5673. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He Y, Zeng HZ, Yu Y, Zhang JS, Duan X,
Zeng XN, Gong FT, Liu Q and Yang B: Resveratrol improves prostate
fibrosis during progression of urinary dysfunction in chronic
prostatitis. Environ Toxicol Pharmacol. 54:120–124. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong L, Done JD, Schaeffer AJ and
Thumbikat P: Experimental autoimmune prostatitis induces microglial
activation in the spinal cord. Prostate. 75:50–59. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng T, Wang R, Zhang TB, Jia DH, Wang
CL, Sun Y and Zhang WX: AB036. Effects and its potential mechanisms
of Cox-2 inhibitors on ejaculation latency of rat with experimental
autoimmune prostatitis. Transl Androl Urol. 5 Suppl 1:AB0362016.
View Article : Google Scholar :
|
|
23
|
Rivero VE, Motrich RD, Maccioni M and
Riera CM: Autoimmune etiology in chronic prostatitis syndrome: An
advance in the understanding of this pathology. Crit Rev Immunol.
27:33–46. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fraga F, Sturny M, Ruoccolo R, Santos R,
Silva R and Stergiopulos N: 139 Angiotensin-(1–7) inhibits
cavernosal fibrosis via attenuation of fibroblast differentiation
to myofibroblast. J Sex Med. 14 Suppl 1:S392017. View Article : Google Scholar
|
|
25
|
Abe M, Kurosawa M, Ishikawa O, Miyachi Y
and Kido H: Mast cell tryptase stimulates both human dermal
fibroblast proliferation and type I collagen production. Clin Exp
Allergy. 28:1509–1517. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kofford MW, Schwartz LB, Schechter NM,
Yager DR, Diegelmann RF and Graham MF: Cleavage of type I
procollagen by human mast cell chymase initiates collagen fibril
formation and generates a unique carboxyl-terminal propeptide. J
Biol Chem. 272:7127–7131. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Jubair S, Levick SP and Janicki JS:
The autocrine role of tryptase in pressure overload-induced mast
cell activation, chymase release and cardiac fibrosis. IJC
Metabolic and Endocr. 10:16–23. 2016. View Article : Google Scholar
|
|
28
|
Beghdadi W, Madjene LC, Claver J, Pejler
G, Beaudoin L, Lehuen A, Daugas E and Blank U: Mast cell chymase
protects against renal fibrosis in murine unilateral ureteral
obstruction. Kidney Int. 84:317–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Globa T, Saptefrţi L, Ceauşu RA, Gaje P,
Cimpean AM and Raica M: Mast cell phenotype in benign and malignant
tumors of the prostate. Pol J Pathol. 65:147–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qi L, Song W, Liu Z, Zhao X, Cao W and Sun
B: Wnt3a promotes the vasculogenic mimicry formation of colon
cancer via wnt/β-catenin signaling. Int J Mol Sci. 16:18564–18579.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Conidi A, van den Berghe V and Huylebroeck
D: Aptamers and their potential to selectively target aspects of
EGF, Wnt/β-catenin and TGFβ-smad family signaling. Int J Mol Sci.
14:6690–6719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pons M, Ali L, Beghdadi W, Danelli L,
Alison M, Madjène LC, Calvo J, Claver J, Vibhushan S, Åbrink M, et
al: Mast cells and MCPT4 chymase promote renal impairment after
partial ureteral obstruction. Front Immunol. 8:4502017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van den Bosch MH, Blom AB, van Lent PL,
van Beuningen HM, Blaney Davidson EN, van der Kraan PM and van den
Berg WB: Canonical Wnt signaling skews TGF-beta signaling in
chondrocytes towards signaling via ALK1 and Smad 1/5/8. Cell
Signal. 26:951–958. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao Z, Chen C, Meng T, Zhang W and Zhou
Q: Resveratrol attenuates renal injury and fibrosis by inhibiting
transforming growth factor-β pathway on matrix metalloproteinase 7.
Exp Biol Med (Maywood). 241:140–146. 2016. View Article : Google Scholar : PubMed/NCBI
|
